Company Summary
The company PHAGE THERAPIES SA is a Joint Stock Company, established in Friday, September 21, 2012, with headquarters in the municipality of LISBOA. The share capital is 50.000,00 €
, and its Economic Activity Code (CNAE) is 72101 Biotechnology research and development
In the sector corresponding to this CAE
with an average EBITDA of 150.932,33 € (profit before depreciation, amortization, financing expenses and taxes).
The average payment term recorded in this sector was 124 days.